• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M. BLUE PLUS VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M. BLUE PLUS VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX804T
Device Problem Mechanical Problem (1384)
Patient Problem Hydrocephalus (3272)
Event Type  Injury  
Manufacturer Narrative
Visual inspection in the first step of our investigation, we performed a visual inspection of the product.We have checked for possible damages, deformations of the housing or other abnormalities.The following observations were made during the visual inspection: no defects or other abnormalities are detected.Permeability test.To check if the m.Blue plus® is blocked, we have performed a permeability test on the shunt system.This test is carried out with the product in the horizontal position with a hydrostatic pressure difference of approx.30 cmh2o in the direction of flow.The test showed that the m.Blue plus® shunt system is permeable.Adjustability test.We have investigated whether the m.Blue and progav 2.0 can be successfully set to each specified pressure setting.Thus indicating whether the valves are fully adjustable within the full range of specified pressure settings (in increments of 4 cmh2o (m.Blue) and in increments of 5 cmh2o (progav 2.0) ).The m.Blue® and the progav® 2.0 were found to be adjustable to all pressure settings.Braking force and brake function test.The braking force and brake function test investigates whether the braking function of the adjustable valves is present and how much force must be exerted on the housing to release the rotor to adjust the valves using the integrated magnet of a specific measurement apparatus of braking force.The braking force of the both valves were within the specified tolerance and the brake function operated as expected.Internal inspection of product.In order to verify whether the investigated shunt system was compromised by the known risks of hydrocephalus therapy, e.G.By a build-up of natural substances (protein, blood, or tissue particles) in the cerebrospinal fluid, we have dismantled the shunt system.After dismantling of the valves, clearly deposits were found in both valves.Results.Based on our investigation, we are not able to substantiate the claim of "non- adjustability".However, we assume that the significant deposits found within the valve may have temporarily caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Event Description
It was reported that there was a problem with a m.Blue plus.The surgeon reported that: "programmable valve not adjusting.No patient harm".Patient information: age: (b)(6) years.Weight: (b)(6) kg.Height: unknown.Gender: male.Implantation: (b)(6) 2019.Removal: (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M. BLUE PLUS VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key11013494
MDR Text Key223590742
Report Number3004721439-2020-00253
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906504793
UDI-Public4041906504793
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K192266
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFX804T
Device Catalogue NumberFX804T
Device Lot Number20042263
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/10/2020
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/05/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age7 YR
Patient Weight30
-
-